Market revenue in 2023 | USD 2,545.2 million |
Market revenue in 2030 | USD 4,486.2 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 77.99% in 2023. Horizon Databook has segmented the Saudi Arabia healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia’s FDA has created a state-of-the-art regulatory framework that supports clinical trials and the development & manufacturing of drugs & medical devices in the country.
Furthermore, the availability of world-class healthcare infrastructure, increase in the number of industry experts trained in western medicine, rapidly growing investments in the contract industry, and increasing government initiatives are factors expected to boost the market in the country.
In March 2018, Saudi Pharmaceutical Industries & Medical Appliances Corporation signed a MoU with AstraZeneca for the launch of a contract manufacturing operation in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account